Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Pelago Bioscience AB
AB
Active
Org 5569241671
Scheeles Väg 1, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 13 years old
56 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pelago Bioscience AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
28M
55M
83M
110M
63M
2020
74M
2021
83M
2022
88M
2023
96M
2024
EBITDA
SEK millions
18M
9M
1M
-7M
-15M
13M
2020
14M
+8%
2021
11M
-21%
2022
-5M
-145%
2023
-12M
-140%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
62 799
73 838
82 790
87 583
96 099
Staff expenses
—
—
—
—
—
EBITDA
12 803
14 031
10 898
−5 456
−12 021
Depreciation & amort.
−3 241
−4 003
−5 109
−3 670
−5 316
EBIT
9 562
10 028
5 789
−9 126
−17 337
Net financials
−42
−16
−90
2 046
894
Profit before tax
7 098
5 572
4 854
3 908
−16 405
Tax
−1 556
−1 182
−758
1 068
3 314
Net profit
5 542
4 390
4 096
4 976
−13 091
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
45 044
60 705
71 681
91 842
86 379
Equity
14 202
18 603
22 699
57 532
50 088
Long-term debt
0
0
94
94
0
Short-term debt
25 176
31 995
37 899
34 216
36 290
Total debt
25 176
31 995
37 993
34 310
36 290
Financial ratios
5-year trend
EBITDA-margin
-12.5%
This company
15.8%
Market median
-179% vs market
2020
2024
Soliditetsgrad
58.0%
This company
38.2%
Market median
+52% vs market
2020
2024
Egenkapitalforrentning
-26.1%
This company
18.4%
Market median
-242% vs market
2020
2024
Nettoresultatgrad
-13.6%
This company
8.1%
Market median
-268% vs market
2020
2024
Aktivomsætning
1.11×
This company
1.12×
Market median
+1% vs market
2020
2024
Gæld/egenkapital
0.72×
This company
0.62×
Market median
+16% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pelago Bioscience AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
